Skip to main content
Premium Trial:

Request an Annual Quote

Celera Offers Database to Israel - Newspaper Says

NEW YORK, Dec 1 - Celera has offered a subscription to its genome database to the Israeli government, the Israeli newspaper Ha’aretz reported Friday.

The company offered the database subscription to Yossi Cucik, the director general of the Israeli prime minister’s office, when he visited the United States in mid-November, the newspaper said.

The database will be made available to academic institutions and government offices in Israel, Cucik told Ha’aretz.

Cucik has arranged a meeting between Celera CEO Craig Venter and Israeli Prime Minister Ehud Barak. The newspaper implied that Venter intended to visit Israel in the near future. Celera was not immediately available for comment.

This report follows Celera’s October announcement that it had licensed its database to Israel's Weizmann Institute of Science. Typically, Celera charges academic and public-sector subscribers between $6,000 and $15,000 per scientist for access to its database .

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more